[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574360":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":34,"collaborators":10,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":10,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":10,"maxAge":10,"enrollmentInfo":44,"targetDuration":47,"studyType":48,"phases":10,"briefSummary":49,"conditions":50,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Kissei Pharmaceutical Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Avacopan treatmented",null,[12],"Drug: Avacopan",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Avacopan","oral administration",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Kazunori Abe, director","CONTACT","0356843575","rinsyousiken@pharm.kissei.co.jp",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":10,"geoPoint":10,"contacts":32},"Research site","RECRUITING","Multiple Locations","Japan","JP",[33],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":35,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100574360","special-drug-use-results-survey-for-long-term-useavacopan-100574360",false,"NCT06758271","Special Drug Use-results Survey for Long-term Use（Avacopan）","Special Drug Use-results Survey for Long-term Use","Inclusion Criteria:\n\n* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan","ALL",{"count":45,"type":46},250,"ESTIMATED","2 Years","OBSERVATIONAL","The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.",[51,52],"Microscopic Polyangiitis (MPA)","Granulomatosis With Polyangiitis (GPA)","2025-01-15",{"date":55,"type":56},"2025-01-17","ACTUAL",{"date":58,"type":56},"2022-07-29",{"date":60,"type":46},"2028-05-31",{"name":5,"class":6},1]